CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $1.38B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.86: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.24BCNY1.38B · vs all stocks (USD)
Revenue (TTM)
338.44MCNY50.52M · vs all stocks (USD)
Profit Margin
-166.21%vs Biotechnology peers
Beta
0.6450xvs all stocks
52-Week Change
-24.45%vs all stocks
Market Capitalization
9.24BCNY1.38B · vs all stocks (USD)
Enterprise Value
7.67BCNY1.15B · vs all stocks (USD)
Forward P/E
-8.36xvs Biotechnology peers
Price to Sales (TTM)
24.81xvs Biotechnology peers
Price to Book (MRQ)
6.55xvs Biotechnology peers
Enterprise to Revenue
22.67xvs Biotechnology peers
Enterprise to EBITDA
-14.21xvs Biotechnology peers
Gross Margin
92.65%vs Biotechnology peers
Profit Margin
-166.21%vs Biotechnology peers
Operating Margin
-193.10%vs Biotechnology peers
Return on Assets (TTM)
-12.73%vs Biotechnology peers
Return on Equity (TTM)
-36.14%vs Biotechnology peers
Revenue (TTM)
338.44MCNY50.52M · vs all stocks (USD)
Revenue per Share (TTM)
0.9210CNYUpdated Sep 22, 2026Quarterly Revenue Growth
240.20%vs Biotechnology peers
Gross Profit (TTM)
312.39MCNY46.63M · vs all stocks (USD)
EBITDA (TTM)
-539.90MCNY-80.59M · vs all stocks (USD)
Net Income (TTM)
-562.52MCNY-83.97M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
325.96%vs Biotechnology peers
Operating Cash Flow (TTM)
-597.36MCNY-89.17M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-603.86MCNY-90.14M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Biotechnology peers
Revenue
230.73MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
16.09MCNYFY2025 · Dec 31, 2025Gross Profit
214.63MCNYFY2025 · Dec 31, 2025Operating Income
-545.56MCNY-81.44M · vs all stocks (USD)
Pre-tax Income
-535.65MCNYFY2025 · Dec 31, 2025Net Income
-535.65MCNYFY2025 · Dec 31, 2025EBIT
-504.24MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-436.92MCNYFY2025 · Dec 31, 2025Research & Development
472.83MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
150.63MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.94MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
35.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
31.41MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.46CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.46CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
366.88MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
366.88MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-535.65MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-538.10MCNYFY2025 · Dec 31, 2025Free Cash Flow
-623.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.54BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-535.65MCNYFY2025 · Dec 31, 2025Other Non-cash Items
36.50MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
6.06MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-45.01MCNYFY2025 · Dec 31, 2025Capital Expenditures
-85.32MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.80BCNYFY2025 · Dec 31, 2025Sale of Investments
2.54BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-340.70MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
892.25MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-660.92MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-30.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
-19.93MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
180.88MCNYFY2025 · Dec 31, 2025Shares Outstanding
366.68MSharesUpdated Sep 22, 2026Float Shares
111.22MSharesUpdated Sep 22, 2026% Held by Insiders
70.36%vs all stocks
% Held by Institutions
5.81%vs all stocks
Total Cash (MRQ)
1.86BCNY277.39M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.07CNYUpdated Sep 22, 2026Total Debt (MRQ)
1.13BCNY169.15M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8842xvs Biotechnology peers
Current Ratio (MRQ)
5.45xvs Biotechnology peers
Book Value per Share (MRQ)
3.50CNYUpdated Sep 22, 2026Total Assets
2.99BCNY446.81M · vs all stocks (USD)
Total Current Assets
2.44BCNYFY2025 · Dec 31, 2025Total Liabilities
1.41BCNYFY2025 · Dec 31, 2025Total Non-current Assets
550.03MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
935.84MCNYFY2025 · Dec 31, 2025Total Current Liabilities
472.72MCNYFY2025 · Dec 31, 2025Cash
1.54BCNYFY2025 · Dec 31, 2025Cash Equivalents
143.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.54BCNYFY2025 · Dec 31, 2025Other Short-term Investments
681.23MCNYFY2025 · Dec 31, 2025Accounts Receivable
21.08MCNYFY2025 · Dec 31, 2025Inventory
96.12MCNYFY2025 · Dec 31, 2025Accounts Payable
95.43MCNYFY2025 · Dec 31, 2025Short-term Debt
169.88MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.47MCNYFY2025 · Dec 31, 2025Long-term Debt
892.80MCNYFY2025 · Dec 31, 2025Common Stock (Book)
366.68MCNYFY2025 · Dec 31, 2025Retained Earnings
-2.95BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.58BCNY236.56M · vs all stocks (USD)
Treasury Stock
20.30MCNYFY2025 · Dec 31, 202552-Week Low
20.07CNYUpdated Sep 22, 202652-Week High
34.48CNYUpdated Sep 22, 202652-Week Change
-24.45%vs all stocks
Beta
0.6450xvs all stocks
50-Day MA
24.08CNYUpdated Sep 22, 2026200-Day MA
26.59CNYUpdated Sep 22, 2026Avg 10-Day Volume
2.03MSharesUpdated Sep 22, 2026Avg 30-Day Volume
3.60MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-1.53CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.93Profit Margin: -1.66
Financial Health
Altman Z-Score 2.86: safe zoneNotable
Altman Z-Score: 2.86
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $1.38B, above the global median of $1.18BNotable
Market cap (USD): 1,378,757,611.484Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Xinhua Pharmaceutical Company Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Jolly Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Oric Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Conmed Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Phibro Animal Health Corporation
Tier 1ProductionApproval-Gated PipelineRule
Pacific Shuanglin Bio-Pharmacy Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Arrivent Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
GenFleet Therapeutics (Shanghai) Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Chengdu Easton Bio Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
EL.En. S.p.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow